When a Premature Baby's Brain Spaces Swell: What New Research Says About Timing, Drains and Shunts

Four studies from 2025 and 2026 on post-haemorrhagic ventricular dilatation, explained for families

When a very premature baby bleeds into the fluid-filled spaces inside the brain, those spaces can swell — a condition doctors call post-haemorrhagic ventricular dilatation. Four studies published in 2025 and 2026 show that this swelling leaves the brain short of oxygen, that hospitals disagree about when to drain it, and that patience with a temporary drain can sometimes spare a child a permanent one.

What is actually happening inside the head

Every brain has four connected chambers, called ventricles, filled with a clear liquid known as cerebrospinal fluid. The fluid is made continuously, circulates around the brain and spinal cord, and is reabsorbed into the bloodstream. In babies born very early, the blood vessels in a small region beside these chambers are fragile, and in the first days of life they can bleed. If the bleed is small, the blood is absorbed and nothing further happens. If it is large, blood clots and debris can block the drainage routes and clog the tiny structures that absorb the fluid. The fluid keeps being made but can no longer leave at the same rate, and the chambers begin to swell.

That swelling is what doctors are looking for when they scan your baby's head with ultrasound, sometimes several times a week. It matters because the growing chambers press outward on brain tissue that is still developing, and because the breakdown products of old blood are themselves irritating to that tissue. Roughly four in ten babies with a serious bleed go on to develop this swelling [1]. Of those, most will need some form of treatment to remove fluid, and about half of the ones who need a device will eventually need a permanent one. The four recent studies described here each take up a different part of the problem: one from Vienna measures what the swelling does to the brain [1], one surveys what hospitals across North America actually do [2], one from Rotterdam asks whether temporary drainage can be stretched out [3], and one from Ankara asks what can be done in the operating theatre [4].

What families used to face, and how the rules changed

For much of the past forty years, the approach was to wait for signs. Doctors had a grading system for brain bleeds published in 1978 and still used today [5], and a ruler-style measurement of the swelling chambers described in 1981 [6] — but the decision to act usually waited for the baby to show something outwardly: a bulging soft spot, a head growing too fast, pauses in breathing, a slowing heart rate.

The trouble is that a premature baby's skull is soft and its plates have not yet fused, so the head can expand a long way before anything looks wrong from the outside. By the time the signs appear, the pressure has often been building for weeks. Research in the early 2000s also showed something that makes the decision genuinely difficult: the swelling does not always get worse. In a meaningful number of babies it settles by itself, and those babies would have been put through procedures for nothing [7]. Parents were, in effect, caught between two kinds of harm.

The balance shifted with a European trial, the Early versus Late Ventricular Intervention Study (ELVIS), carried out in neonatal units including centres in the Netherlands, the United Kingdom and Spain. It randomly assigned 126 babies either to have fluid removed as soon as the measurement crossed a defined line, or to wait until it crossed a line 4 mm higher [8]. The headline result was not clear-cut, but at two years of age the children treated earlier had done better [9]. A 2026 re-analysis of the same children put the probability that waiting caused harm at 91 to 99 per cent, and estimated that treating about seven babies earlier would prevent one bad outcome [10]. An international group of doctors had already turned this thinking into a step-by-step plan built around regular ultrasound rather than waiting for symptoms [11].

Measuring what the swelling does to the brain

The first of the four new studies, from the Medical University of Vienna in Austria, tried to capture the effect of the swelling directly rather than inferring it [1]. The team used a painless sensor placed on the forehead, which shines near-infrared light through the skin and skull and measures how much oxygen the brain tissue underneath is using. They monitored 154 very premature babies with brain bleeds — most born at around 25 weeks and weighing about 800 grams — from the day the bleed was found until around their original due date. Altogether they collected close to 30,000 hours of recording, which is among the most detailed pictures of this problem ever assembled.

The results are stark. The bigger the bleed, the lower the brain's oxygen levels. But the swelling added a penalty of its own, on top of the bleed. Among babies with the most severe type of bleed, those whose chambers did not swell spent about a tenth of the monitored time below the oxygen level doctors consider safe. Those whose chambers did swell spent about seven-tenths of the time below it. And the more drainage procedures a baby needed, the lower their oxygen levels ran — babies who needed several procedures were clearly worse off than those who needed one or none. Reassuringly, babies who needed just one procedure looked much like babies who needed none at all.

This is the strongest argument yet that swollen chambers are not simply a sign that a baby is unwell. They appear to be an ongoing problem in their own right, and one that treatment can partly reverse.

Why hospitals do not all do the same thing

The second study asked a different question: what do hospitals actually do? Researchers surveyed 49 of the highest-level neonatal units in North America, and 40 replied [2]. Only twelve had a written plan for managing this condition at all. Eleven said they had an informal understanding, and seventeen had no agreed approach.

Among the twelve with a written plan, some things were consistent: all of them use regular head ultrasounds, and they agree closely on the measurement thresholds that should trigger surgery. But other things were not. Some units use one ruler measurement, others use a different ratio. A third act purely on the scan; the rest also take the baby's symptoms into account. Half use a lumbar puncture — a needle in the lower back to draw off fluid — as a first step; half do not. Fewer than half write down what should happen for follow-up after surgery.

If you are comparing notes with another family, this is why your baby's care may look different from theirs. It is not that one team is right and the other wrong, but that the evidence has real gaps, and different teams have made different reasonable choices within them.

Can a temporary drain avoid a permanent one?

The usual sequence is to start with temporary measures — draining fluid with a needle, or placing a small reservoir under the scalp that connects to the chamber and can be tapped repeatedly. If the swelling settles, the reservoir comes out. If it does not, a permanent shunt is placed: a thin tube running under the skin from the brain to the abdomen, which drains fluid for life and sometimes needs replacing.

Dutch national guidance used to convert babies to a permanent shunt after 28 days of tapping the reservoir. A team at the Erasmus MC-Sophia Children's Hospital in Rotterdam asked whether that was too rigid [3]. Among 55 babies treated over ten years, 23 were tapped for longer than 28 days because their chambers were improving but still needed occasional draining, and eight of those never needed a permanent shunt. Overall 27 per cent ended up with a shunt, against a projected 42 per cent had everyone been converted at the 28-day mark, and the longer tapping did not cause more infections or other problems. This is not proof, because the babies tapped longer were chosen precisely because they were doing well. But it suggests the 28-day rule is better treated as a moment to reassess than a deadline.

Washing the old blood out

The fourth study looked at babies for whom a permanent shunt was already unavoidable [4]. At a hospital in Ankara, Türkiye, surgeons treating 73 such infants used a fine endoscope in 42 of them during the shunt operation, gently rinsing old blood and debris out of the chambers with warmed fluid before placing the shunt; the other 31 had the shunt alone. The rinse added about 26 minutes of operating time and no extra blood loss. Afterwards, 21 per cent of the rinsed group needed a further operation on the shunt, against 55 per cent of those who had the shunt alone. Complications and deaths were also lower with the rinse, though not clearly enough to be certain.

What this means for your baby

These are four observational studies, not trials, so they show patterns rather than prove causes. Still, a consistent picture emerges. Swollen chambers are worth taking seriously and worth treating in good time; needing one drainage procedure is not the same as needing several; and a permanent shunt is common but not inevitable, so a slow, carefully watched exit from temporary drainage is a legitimate goal rather than a delay. The stakes are real: among the most premature babies this condition carries high rates of death or lasting developmental difficulty [12], and effects on quality of life can still be measured at ten years of age [13].

Questions worth asking your team include: does this unit have a written plan for managing the swelling, and what triggers the next step? How often will the scans be done? If a reservoir is placed, what would need to happen for it to come out rather than be converted to a shunt?

What researchers are working on next

Two questions stand out. The first is whether brain-oxygen monitoring, of the kind used in Vienna, could help decide when to intervene for an individual baby rather than simply describing a group. The second is whether the two tactics described here — more patience with temporary drainage, and rinsing the chambers during surgery — work better together than alone. Neither has been tested in a randomised trial. For families, this is an area where care is still changing, and asking what your unit does, and why, is entirely reasonable.

References

  1. Elis J, Klein L, Steiner M, Moser K, Giordano V, Vignolle GA, et al. Impact of posthemorrhagic ventricular dilatation on cerebral oxygenation in preterm infants with intraventricular hemorrhage. Pediatric Research. 2026;99(4):1398–1406. doi:10.1038/s41390-025-04738-y ↩
  2. Coletti K, Lee SS, Cohen S, Dizon MLV, Hersh DS, Mietzsch U, et al. Post-hemorrhagic ventricular dilatation: comparison of management pathways among North American level IV NICUs. Journal of Perinatology. 2026;46:971–977. doi:10.1038/s41372-026-02595-z ↩
  3. Gačević D, van den Bosch GE, Knol R, Smit LS, Spoor JKH. Prolonged puncturing decreases ventriculoperitoneal shunt insertion rate in neonates with posthemorrhagic ventricular dilatation. Child's Nervous System. 2026;42(1):317. doi:10.1007/s00381-026-07408-4 ↩
  4. Kayhan S, Ezgu MC, Yilmaz E, Izci Y. Association of same-session neuroendoscopic lavage with ventriculoperitoneal shunting and outcomes in post-hemorrhagic hydrocephalus: a retrospective cohort study. Cureus. 2025;17(12):e99428. doi:10.7759/cureus.99428 ↩
  5. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics. 1978;92(4):529–534. doi:10.1016/S0022-3476(78)80282-080282-0) ↩
  6. Levene MI, Starte DR. A longitudinal study of post-haemorrhagic ventricular dilatation in the newborn. Archives of Disease in Childhood. 1981;56(12):905–910. doi:10.1136/adc.56.12.905 ↩
  7. Murphy BP, Inder TE, Rooks V, Taylor GA, Anderson NJ, Mogridge N, et al. Posthaemorrhagic ventricular dilatation in the premature infant: natural history and predictors of outcome. Archives of Disease in Childhood — Fetal and Neonatal Edition. 2002;87(1):F37–F41. doi:10.1136/fn.87.1.f37 ↩
  8. de Vries LS, Groenendaal F, Liem KD, Heep A, Brouwer AJ, van 't Verlaat E, et al. Treatment thresholds for intervention in posthaemorrhagic ventricular dilation: a randomised controlled trial. Archives of Disease in Childhood — Fetal and Neonatal Edition. 2019;104(1):F70–F75. doi:10.1136/archdischild-2017-314206 ↩
  9. Cizmeci MN, Groenendaal F, Liem KD, van Haastert IC, Benavente-Fernández I, van Straaten HLM, et al. Randomized controlled early versus late ventricular intervention study in posthemorrhagic ventricular dilatation: outcome at 2 years. Journal of Pediatrics. 2020;226:28–35.e3. doi:10.1016/j.jpeds.2020.08.014 ↩
  10. Cizmeci MN, de Vries LS, Whitelaw A, Steggerda SJ, Liem KD, Benavente-Fernández I, et al. Early versus Late Ventricular Intervention Study (ELVIS) in post-hemorrhagic ventricular dilatation: Bayesian reanalysis of brain injury and outcomes. Pediatric Research. 2026. doi:10.1038/s41390-026-05172-4 ↩
  11. El-Dib M, Limbrick DD, Inder T, Whitelaw A, Kulkarni AV, Warf B, et al. Management of post-hemorrhagic ventricular dilatation in the infant born preterm. Journal of Pediatrics. 2020;226:16–27.e3. doi:10.1016/j.jpeds.2020.07.079 ↩
  12. Shankaran S, Bajaj M, Natarajan G, Saha S, Pappas A, Davis AS, et al. Outcomes following post-hemorrhagic ventricular dilatation among extremely low gestational age infants. Journal of Pediatrics. 2020;226:36–44.e3. doi:10.1016/j.jpeds.2020.07.080 ↩
  13. Rela A, Jary S, Williams C, Blair P, Hollingworth W, et al. Quality of life at a 10-year follow-up of children born preterm with post-hemorrhagic ventricular dilatation: a cohort study. Neonatology. 2023;120(6):690–698. doi:10.1159/000533355 ↩